Company Profiles

driven by the PitchBook Platform

Embera NeuroTherapeutics

Description

Provider of treatment for smoking cessation, cocaine dependence and other addictions. The company is developing an addiction pharmaceutical (EMB-001) that targets specific and complementary brain functions and drive the craving and relapse associated with these disorders.

2007

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$11.1M

Latest Deal Amount

$22M

Total Amount Raised

Description

Provider of treatment for smoking cessation, cocaine dependence and other addictions. The company is developing an addiction pharmaceutical (EMB-001) that targets specific and complementary brain functions and drive the craving and relapse associated with these disorders.

Website:

www.emberaneuro.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Pharmaceuticals and Biotechnology

Primary Office

365 Boston Post Road Suite 212 Sudbury, MA 01776United States +1 (978) 579-4156
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Embera NeuroTherapeutics's full profile, request a free trial.

    Embera NeuroTherapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Embera NeuroTherapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Embera NeuroTherapeutics Investors (7)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    BVM CapitalVenture CapitalMinority000 0000000 0000
    HRA PharmaPE-Backed CompanyMinority000 0000000 0000
    Keiretsu CapitalVenture CapitalMinority000 0000000 0000
    Keiretsu ForumVenture CapitalMinority000 0000000 0000
    Louisiana FundVenture CapitalMinority000 0000000 0000
    BVM Capital Venture Capital
    HRA Pharma PE-Backed Company
    Keiretsu Capital Venture Capital
    Keiretsu Forum Venture Capital
    Louisiana Fund Venture Capital

    Embera NeuroTherapeutics Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    Robert LinkeChief Executive Officer, Board Member & President
    Nicholas Geoders Ph.DChief Scientific Officer & Director
    Gary ConnorDirector of Clinical Operations
    Carol Gloff Ph.DConsulting Vice President, Pre-Clinical Development and Regulatory Affairs
    Julie Straub Ph.DVice President, CMC and Nonclinical Development
    Robert Linke Chief Executive Officer, Board Member & President
    Nicholas Geoders Ph.D Chief Scientific Officer & Director
    Gary Connor Director of Clinical Operations
    Carol Gloff Ph.D Consulting Vice President, Pre-Clinical Development and Regulatory Affairs
    Julie Straub Ph.D Vice President, CMC and Nonclinical Development

    Embera NeuroTherapeutics Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Eirn Gainer Ph.DHRA PharmaChief Executive Officer & President000 0000
    Franz Hefti Ph.DSelfBoard Member000 0000
    Joseph LovettLouisiana FundManaging Director000 0000
    Robert LinkeEmbera NeuroTherapeuticsChief Executive Officer, Board Member & President000 0000
    Ross Barrett JDBVM CapitalGeneral Partner & Co-Founder000 0000
    Eirn Gainer Ph.D Chief Executive Officer & President HRA Pharma
    Franz Hefti Ph.D Board Member Self
    Joseph Lovett Managing Director Louisiana Fund
    Robert Linke Chief Executive Officer, Board Member & President Embera NeuroTherapeutics
    Ross Barrett JD General Partner & Co-Founder BVM Capital
    Request full access to PitchBook